Vantictumab

(Synonyms: OMP-18R5)
1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

Vantictumab (OMP-18R5) is a fully human IgG2 monoclonal antibody. Vantictumab inhibits Wnt pathway signaling by binding to FZD1/2/5/7/8 receptors. Vantictumab can be studied against cancers through direct actions on tumor cells, including CSCs, and effects on the stroma, such as metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.00%
  • No. CAS: 1345009-45-1
  • Peso molecular:143.16 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Vantictumab

More

Ver todos los productos específicos de isoformas Wnt

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00